News 06.06.17

PimBio vestigt zich op Pivot Park

Per 1 juni zijn de deuren van het kantoor van PimBio op Pivot Park geopend.

Read more
News 31.05.17

NTRC publishes target residence time-guided optimization of TTK inhibitors

This week, NTRC published results from its TTK (Mps1) drug discovery programme in the Journal of Molecular Biology.

Read more
News 31.05.17

Pluriomics BV partners with Pivot Park Screening Centre

Pluriomics partners with Pivot Park Screening Centre for Cardiovascular drug discovery services.

Read more
News 16.05.17

Synaffix Secures End-to-End Patent Protection of Its ADC Technology Platform as Its HydraSpace™ Patent Grants in the United States

Synaffix announced that a key patent covering its HydraSpace™ spacer technology has been granted by the US Patent and Trademark Office.

Read more
News 03.04.17

Lead Pharma Achieves Second Milestone for Development of Autoimmune Diseases Treatments in Sanofi Collaboration

Lead Pharma announced that it has achieved a second milestone under its research collaboration with Sanofi.

Read more
News 03.04.17

Rob Prins nieuwe voorzitter Raad van Bestuur Pivot Park

Rob Prins vervangt per 1 april Jan Pelle als voorzitter van de Raad van Bestuur van Pivot Park.

Read more
News 29.03.17

Enterprise System Partners and TraceLink Form Strategic Alliance

Enterprise System Partners announced it has established a strategic partnership with TraceLink.

Read more
News 21.03.17

New study in Oncotarget shows that stable aneuploid cells are more sensitive to TTK inhibition than chromosomally unstable cell lines

Stable aneuploid tumor cells are more sensitive to small molecule inhibitors of TTK than chromosome instable cells.

Read more
News 07.03.17

New at Pivot Park: PerkinElmer OneSource

Since mid-February OneSource is a new occupant in the Pivot Park community.

Read more